Wednesday, July 22, 2026

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

U.S.-ROK Alliance: How the New Defense Strategy Affects China Relations in 2026

U.S. Deputy Secretary Colby emphasizes stronger U.S.-ROK ties to counter China's influence amidst evolving defense strategies.

Dae Hyeon Moon

Daewoong Pharmaceutical and Puzzle AI to Supply AI Medical Record Solution CL Note

Daewoong Pharmaceutical partners with Puzzle AI to enhance digital healthcare with CL Note, streamlining hospital operations and patient care.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Dong-A Chammed Unveils Plans to Enter the In Vitro Diagnostic Blood Coagulation Testing Market

Dong-A Chammed will showcase innovative products at the 2026 Spring Symposium, aiming to expand into blood coagulation testing.

Solum Healthcare Announces AI-Based Urine Test for Cancer at AACR Annual Meeting 2026

Solum Healthcare presented AI-driven non-invasive cancer detection using urine samples at AACR 2026, attracting global interest and discussions.

Angel Robotics blurs line between healthcare and industry with wearable robots

Angel Robotics is enhancing rehabilitation and industrial safety with wearable robots, targeting gait assistance and reducing musculoskeletal disorders.

Hugel holds ‘Letybo’ training in Indonesia to boost competitiveness and brand awareness

Hugel expands in Indonesia with a training program for Letybo, enhancing local medical professionals' skills and brand loyalty.

Global AI Driven Rare Disease Diagnostics Firm 3Billion Enters the U.S. Insurance Market

3Billion is expanding globally, entering the U.S. insurance market, enhancing diagnostics, and pursuing drug development for growth.

Huons to Absorb Huons Life Science: Key Insights on the June 2026 Merger

Huons Group will merge its pharmaceutical operations with Huons Life Science to enhance efficiency and competitiveness by June.

Discover the Breakthroughs of Korea’s ARPA-H Project at BIO KOREA 2026!

The K-Health Future Promotion Team will unveil interim results of the Korean-style ARPA-H project at BIO KOREA 2026, addressing healthcare challenges.

Wontech to host ‘Wave Tokyo’ in Japan, officially launch SANDRO Dual

Wontech will host "Wave Tokyo" on April 26 to launch SANDRO Dual, expanding its presence in Asia after "Wave Beijing."

Carelabs enhances ‘HealO’ service to strengthen cancer treatment information search

Carelabs upgraded its HealO platform for cancer care, enhancing information access from diagnosis to recovery for patients and caregivers.

South Korea’s ARPA-H Project Revolutionizes Elderly Mental Health Solutions

South Korea will officially enter 'super-aged society' by late 2024 or early 2025, raising concerns over elderly mental health issues.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Top News

- Our Sponsors Ad -

Follow us